PCSK9 and LDLR trafficking in hepatocytes

被引：0
|
作者：
Zhang, Da-Wei [1 ]
Garuti, Rita [1 ]
Lagace, Tom [1 ]
Horton, Jay [1 ]
Cohen, Jonathan C. [1 ]
Hobbs, Helen H. [1 ]
机构：
[1] Univ Texas, SW Med Ctr, Dallas, TX USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2007年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E115 / E115
页数：1
相关论文
共 50 条
  • [41] Associations of serially measured PCSK9, LDLR and MPO with clinical outcome in heart failure
    Bouwens, Elke
    Schuurman, Anne-Sophie
    Akkerhuis, K. Martijn
    Manintveld, Olivier C.
    Caliskan, Kadir
    van Ramshorst, Jan
    Germans, Tjeerd
    Umans, Victor A. W. M.
    Boersma, Eric
    Kardys, Isabella
    BIOMARKERS IN MEDICINE, 2021, 15 (04) : 247 - 255
  • [42] LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers
    Ochoa, Eguzkine
    Iriondo, Mikel
    Manzano, Carmen
    Fullaondo, Asier
    Villar, Irama
    Ruiz-Irastorza, Guillermo
    Zubiaga, Ana M.
    Estonba, Andone
    PLOS ONE, 2016, 11 (01):
  • [43] Effects of LDL and oxLDL on expression of PCSK9 and LDLR in THP-1 macrophages
    Liu Lu-Shan
    Cheng Yan-Li
    Xie Min
    Yang Qiong
    Pan Li-Hong
    Jiang Zhi-Sheng
    Tang Chao-Ke
    Wei Dang-Heng
    Tang Zhi-Han
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2008, 35 (05) : 540 - 547
  • [44] Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment
    Maxwell, KN
    Fisher, EA
    Breslow, JL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) : 2069 - 2074
  • [45] Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients
    Hori, Mika
    Ohta, Naotaka
    Takahashi, Atsushi
    Masuda, Hiroaki
    Isoda, Rieko
    Yamamoto, Suguru
    Son, Cheol
    Ogura, Masatsune
    Hosoda, Kiminori
    Miyamoto, Yoshihiro
    Harada-Shiba, Mariko
    ATHEROSCLEROSIS, 2019, 289 : 101 - 108
  • [46] Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India
    Lakshmi Lavanya Reddy
    Swarup A. V. Shah
    Chandrashekhar K. Ponde
    Jamshed J. Dalal
    Raj G. Jatale
    Reeta J. Dalal
    Rajesh M. Rajani
    Sudhir K. Pillai
    Chander V. Vanjani
    Tester F. Ashavaid
    Journal of Human Genetics, 2021, 66 : 983 - 993
  • [47] Gum Arabic Acutely Inhibit PCSK9 and Upregulate LDLr in HepG2
    Abulola, Hatim
    Dybel, Stacey
    Ochin, Chinedu
    Ali, Mohamed
    Garelnabi, Mahdi
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [48] PCSK9 inhibitors
    Farnier, Michel
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (03): : 66 - 70
  • [49] PCSK9 inhibitors
    Farnier, Michel
    CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (03) : 251 - 258
  • [50] The mystery of PCSK9
    Attie, AD
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) : 1337 - 1339
12345